Wearable Devices for Physical Monitoring of Heart: A Review.

Q2 Biochemistry, Genetics and Molecular Biology BMC Proceedings Pub Date : 2022-05-02 DOI:10.3390/bios12050292
Guillermo Prieto-Avalos, Nancy Aracely Cruz-Ramos, Giner Alor-Hernández, José Luis Sánchez-Cervantes, Lisbeth Rodríguez-Mazahua, Luis Rolando Guarneros-Nolasco
{"title":"Wearable Devices for Physical Monitoring of Heart: A Review.","authors":"Guillermo Prieto-Avalos, Nancy Aracely Cruz-Ramos, Giner Alor-Hernández, José Luis Sánchez-Cervantes, Lisbeth Rodríguez-Mazahua, Luis Rolando Guarneros-Nolasco","doi":"10.3390/bios12050292","DOIUrl":null,"url":null,"abstract":"<p><p>Cardiovascular diseases (CVDs) are the leading cause of death globally. An effective strategy to mitigate the burden of CVDs has been to monitor patients' biomedical variables during daily activities with wearable technology. Nowadays, technological advance has contributed to wearables technology by reducing the size of the devices, improving the accuracy of sensing biomedical variables to be devices with relatively low energy consumption that can manage security and privacy of the patient's medical information, have adaptability to any data storage system, and have reasonable costs with regard to the traditional scheme where the patient must go to a hospital for an electrocardiogram, thus contributing a serious option in diagnosis and treatment of CVDs. In this work, we review commercial and noncommercial wearable devices used to monitor CVD biomedical variables. Our main findings revealed that commercial wearables usually include smart wristbands, patches, and smartwatches, and they generally monitor variables such as heart rate, blood oxygen saturation, and electrocardiogram data. Noncommercial wearables focus on monitoring electrocardiogram and photoplethysmography data, and they mostly include accelerometers and smartwatches for detecting atrial fibrillation and heart failure. However, using wearable devices without healthy personal habits will cause disappointing results in the patient's health.</p>","PeriodicalId":9046,"journal":{"name":"BMC Proceedings","volume":"2 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138373/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Proceedings","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bios12050292","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 0

Abstract

Cardiovascular diseases (CVDs) are the leading cause of death globally. An effective strategy to mitigate the burden of CVDs has been to monitor patients' biomedical variables during daily activities with wearable technology. Nowadays, technological advance has contributed to wearables technology by reducing the size of the devices, improving the accuracy of sensing biomedical variables to be devices with relatively low energy consumption that can manage security and privacy of the patient's medical information, have adaptability to any data storage system, and have reasonable costs with regard to the traditional scheme where the patient must go to a hospital for an electrocardiogram, thus contributing a serious option in diagnosis and treatment of CVDs. In this work, we review commercial and noncommercial wearable devices used to monitor CVD biomedical variables. Our main findings revealed that commercial wearables usually include smart wristbands, patches, and smartwatches, and they generally monitor variables such as heart rate, blood oxygen saturation, and electrocardiogram data. Noncommercial wearables focus on monitoring electrocardiogram and photoplethysmography data, and they mostly include accelerometers and smartwatches for detecting atrial fibrillation and heart failure. However, using wearable devices without healthy personal habits will cause disappointing results in the patient's health.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用于心脏物理监测的可穿戴设备:综述。
心血管疾病(CVDs)是导致全球死亡的主要原因。减轻心血管疾病负担的有效策略是利用可穿戴技术监测患者在日常活动中的生物医学变量。如今,技术进步促进了可穿戴设备技术的发展,缩小了设备的尺寸,提高了生物医学变量传感的准确性,使其成为能耗相对较低的设备,能够管理病人医疗信息的安全性和隐私性,适应任何数据存储系统,与病人必须去医院做心电图的传统方案相比,成本合理,从而为心血管疾病的诊断和治疗提供了一个重要的选择。在这项工作中,我们回顾了用于监测心血管疾病生物医学变量的商业和非商业可穿戴设备。我们的主要研究结果表明,商用可穿戴设备通常包括智能腕带、贴片和智能手表,它们通常监测心率、血氧饱和度和心电图数据等变量。非商业可穿戴设备侧重于监测心电图和光电血压数据,它们大多包括用于检测心房颤动和心力衰竭的加速度计和智能手表。然而,在没有健康个人习惯的情况下使用可穿戴设备,会给患者的健康带来令人失望的结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BMC Proceedings
BMC Proceedings Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)
CiteScore
3.50
自引率
0.00%
发文量
6
审稿时长
10 weeks
期刊最新文献
Improving access to services in neuro-developmental disability: proceedings of a national meeting to advance community capacity. Managing conflict styles to accelerate leadership effectiveness. World Health Organization African Region national heads of units of diagnostics and laboratory services meetings proceedings. How to construct and deliver an elevator pitch: a formula for the research scientist. Meeting report of the seventh annual Tri-Service Microbiome Consortium Symposium.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1